Regional Observation of the Metabolic Syndrome (ORSA)

AstraZeneca

Status: Completed

Conditions: Metabolic Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT00874952

NIS-CIT-DUM-2007/1

Details and patient eligibility

About

The aim of the study, is to assess the prevalence of metabolic syndrome in Italy on a regional basis, defined according to National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII) guidelines criteria.

Enrollment: 1,600 estimated patients

Sex: All

Ages: 40 to 74 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed informed consent
• Laboratory analysis (lipidic profile and glycemia) performed in the last year

Exclusion criteria

• Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
• Pregnancy or breast feeding
• Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs